Minos Biosciences
French tech company | Builders Republic
About
Minos Biosciences, a deeptech spin-off of ESPCI Paris-PSL founded in 2020, develops a high-throughput single-cell analysis platform combining microfluidics, molecular biology and data analysis, with applications in oncology, immunology and prenatal diagnostics.
Key facts
- Status
- Morte
- Sectors
- Healthcare & Life Sciences
- Founded
- 2020
- City
- PARIS
- Region
- IDF
Notes
Placée en liquidation judiciaire en septembre 2025 (BODACC).